Evaluation of Safety and Dosimetry of
177Lu-DOTA-ZOL
bisphosphonate
bone metastasis
dosimetry
radionuclide therapy
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
26
08
2020
accepted:
01
12
2020
pubmed:
10
1
2021
medline:
6
1
2022
entrez:
9
1
2021
Statut:
ppublish
Résumé
Palliative treatment of bone metastasis using radiolabeled bisphosphonates is a well-known concept proven to be safe and effective. A new therapeutic radiopharmaceutical for bone metastasis is
Identifiants
pubmed: 33419945
pii: jnumed.120.255851
doi: 10.2967/jnumed.120.255851
pmc: PMC8833870
doi:
Substances chimiques
Heterocyclic Compounds, 1-Ring
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1126-1132Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Br J Radiol. 2017 Aug;90(1077):20160748
pubmed: 28654303
Oncotarget. 2016 Mar 15;7(11):12477-88
pubmed: 26871285
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):21-33
pubmed: 26266887
Ann Nucl Med. 2019 Jun;33(6):404-413
pubmed: 30877560
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
EJNMMI Res. 2017 Nov 3;7(1):88
pubmed: 29098485
J Nucl Med. 2015 Oct;56(10):1513-9
pubmed: 26315829
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):79-88
pubmed: 25070686
Bone Res. 2015 Jul 14;3:15024
pubmed: 26273541
Urology. 2016 Jun;92:6-13
pubmed: 26768714
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1238-50
pubmed: 20411259
Ann Nucl Med. 2015 Jul;29(6):506-11
pubmed: 25903357
EJNMMI Res. 2019 Nov 28;9(1):102
pubmed: 31781962
Drug Healthc Patient Saf. 2010;2:121-37
pubmed: 21701624
J Nucl Med Technol. 1998 Jun;26(2):80-3; quiz 85-6
pubmed: 9604827
Clin Nucl Med. 2013 Feb;38(2):88-92
pubmed: 23334120
J Nucl Med. 2003 Jun;44(6):953-60
pubmed: 12791825
EJNMMI Radiopharm Chem. 2017;1(1):14
pubmed: 29564390
Cancer Biother Radiopharm. 2015 Mar;30(2):94-9
pubmed: 25714451
World J Nucl Med. 2011 Jul;10(2):122-38
pubmed: 22144871
Ann ICRP. 2018 Oct;47(3-4):187-195
pubmed: 29664326
Radiographics. 1989 Mar;9(2):271-81
pubmed: 2467331
Int J Radiat Oncol Biol Phys. 1991 May 15;21(1):109-22
pubmed: 2032882
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1976-83
pubmed: 26227531
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1138-46
pubmed: 19247653
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51
pubmed: 26318602
Curr Radiopharm. 2018;11(3):223-230
pubmed: 29866026
Front Med (Lausanne). 2017 May 01;4:46
pubmed: 28507988
Pharmaceuticals (Basel). 2017 May 18;10(2):
pubmed: 28524118
Cancer Biother Radiopharm. 2008 Apr;23(2):202-13
pubmed: 18454689
J Nucl Med. 2001 Mar;42(3):492-8
pubmed: 11337528
Surgery. 2006 Dec;140(6):968-76; discussion 976-7
pubmed: 17188146
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200
pubmed: 19915839